Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa

Clinical trial NCT01468207 · COMPLETED

Trial details

NCT number: NCT01468207
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2011-11-01
Primary completion: 2014-01-01
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.